A network dedicated to early phase trials of treatments for children with brain cancer will be phased out. A respected network of hospitals and cancer centers is halting enrollment in clinical trials ...

The National Cancer Institute is phasing out the Pediatric Brain Tumor Consortium, a prominent clinical trial network that ...

The FDA has approved a new drug called Modeyso for the treatment of diffuse midline glioma (DMG), a rare and aggressive brain ...

A clinical trial of an experimental cell therapy shows promising results for glioblastoma patients, with tumors disappearing ...

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

Art Sullivan, a 38-year-old Ironman athlete, and Josh Lehman, 48, who works at the University of Rochester, are connected by ...

Beware these 5 signs of a ‘highly invasive’ brain cancer — patients typically survive only 15 months By Tracy Swartz Published Aug. 11, 2025, 6:00 a.m. ET ...

Father outliving his brain cancer prognosis shares his battle and love for life Nicholas was diagnosed with stage four glioblastoma in July 2017.

Clare Smerdon, 37, was diagnosed with a grade 4 astrocytoma — just weeks after her son Teddy turned 13 months.